Prioritizing Pharmaceuticals for Environmental Monitoring in Greece: A Comprehensive Review of Consumption, Occurrence, and Ecological Risk
Toxics · 30.12.2025 · 14 (1) · 45
DOI: 10.3390/toxics14010045 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Toxics, online erschienen am 30.12.2025. Verfasst von Konstantina-Roxani Chatzipanagiotou und 4 weiteren Autor:innen. Beteiligte Einrichtung: IRES-Innovation in Research and Engineering Solutions SNC, Silversquare Europe, Square de Meeûs 35, 1000 Brussels, Belgium. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, European Union’s Horizon 2020 research and innovation programme ENVIROMED.
Abstract (Originalsprache)
Pharmaceuticals are increasingly recognized as contaminants of emerging concern, yet monitoring strategies often do not reflect actual consumption patterns or ecological risk. Greece presents a particularly relevant case due to high pharmaceutical use and fragmented monitoring data. In the present study, 359 pharmaceuticals, metabolites, and transformation products were reviewed, as reported in monitoring studies in Greek wastewater, surface waters, and drinking water. Consumption data (from the Organization for Economic Co-operation and Development, OECD), environmental occurrence (from 55 studies), and ecotoxicity thresholds (i.e., from the NORMAN Database) were integrated to calculate risk quotients (RQs) and assess monitoring gaps. RQ values were derived for 241 compounds: 38 (16%) high-risk, 60 (25%) medium-risk, and 143 (59%) low-risk. High-risk substances included several NSAIDs, macrolide and fluoroquinolone antibiotics, synthetic hormones, contrast agents, and triclosan. Major under-monitoring was observed for widely consumed classes A and B, while antibiotics, NSAIDs, antidepressants, and analgesics were disproportionately targeted. Several metabolites showed higher RQs than their parent compounds but were rarely analyzed. These findings reveal significant mismatches between pharmaceutical use, environmental occurrence, and ecological risk in Greece. Results support adopting risk-based prioritization for environmental monitoring and align with ongoing updates to EU water policy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- IRES-Innovation in Research and Engineering Solutions SNC, Silversquare Europe, Square de Meeûs 35, 1000 Brussels, Belgium.
ORCID-Profile: Konstantina-Roxani Chatzipanagiotou, Foteini Petrakli, Elias P Koumoulos
Förderung
- European Commission
- European Union’s Horizon 2020 research and innovation programme ENVIROMED
Zitieren
APA
Chatzipanagiotou, K. R., Bon, A., Petrakli, F., Antonaropoulos, G., & Koumoulos, E. P. (2025). Prioritizing Pharmaceuticals for Environmental Monitoring in Greece: A Comprehensive Review of Consumption, Occurrence, and Ecological Risk. Toxics, 14(1), 45. https://doi.org/10.3390/toxics14010045
Vancouver
Chatzipanagiotou KR, Bon A, Petrakli F, Antonaropoulos G, Koumoulos EP. Prioritizing Pharmaceuticals for Environmental Monitoring in Greece: A Comprehensive Review of Consumption, Occurrence, and Ecological Risk. Toxics. 2025;14(1):45. doi:10.3390/toxics14010045
BibTeX
@article{Chatzipanagiotou2025,
author = {Chatzipanagiotou, Konstantina-Roxani and Bon, Adamantia and Petrakli, Foteini and Antonaropoulos, George and Koumoulos, Elias P},
title = {Prioritizing Pharmaceuticals for Environmental Monitoring in Greece: A Comprehensive Review of Consumption, Occurrence, and Ecological Risk},
journal = {Toxics},
year = {2025},
volume = {14},
number = {1},
pages = {45},
doi = {10.3390/toxics14010045}
}
EUVIMED